Biocompatibility of haemodialysis membranes.
Haemodialysis is widely used as a method of treatment for renal failure; it relies on diffusion across a semipermeable membrane. The exposure of blood to the membrane is associated with a rapid transient fall in white cells, activation of the complement system and a fall in arterial oxygenation. The interrelationship between these phenomena, their dependence on the type of membrane used and their clinical implications are reviewed and discussed.
D002482:Cellulose; D003167:Complement Activation; D006801:Humans; D000860:Hypoxia / Q000150:complications / Q000209:etiology* / Q000378:metabolism; D007688:Kidneys, Artificial; D007970:Leukopenia / Q000150:complications / Q000209:etiology* / Q000276:immunology; D008566:Membranes; D008567:Membranes, Artificial; D011108:Polymers; D006435:Renal Dialysis / Q000009:adverse effects*
D008567:Membranes, Artificial; D011108:Polymers; D002482:Cellulose